Stem cells

The London Project to Cure Blindness reported completion of the first procedure to implant a patch seeded with retinal cells derived from an embryo. The treatment is for macular degeneration, a leading cause of vision loss

Following a positive ruling on patents and a decision to maintain funding for embryonic stem cell research in Horizon 2020, things are looking up for regenerative medicine. Now further support is needed to deliver on the therapeutic potential, experts say in a Science|Business Webinar

The European Parliament’s Research, Industry and Energy Committee has adopted a tough negotiating position on the EU’s next research funding programme.

Experts say cutting embryonic stem cell funding in Horizon 2020 will threaten progress Europe is making in developing safe, effective and well-regulated cell therapies - and in creating an economically important regenerative medicine sector

Europe currently leads the world in therapeutic applications of regenerative medicine. It has seen companies spin out from universities and approved products reaching the market. Science|Business brought together experts to discuss how to build on these foundations

Positive clinical data, increases in federal funding and the first regulatory approval of a manufactured stem cell product mean momentum is building in the US. With the re-election of President Obama, this is likely to continue

The EU must continue to support human embryonic stem cell research to maintain its lead in regenerative medicine. The upcoming Irish Presidency needs to recognise the importance of this research and resist calls for a ban on funding in Horizon 2020